Literature DB >> 22959259

The role of MRI and CT of the brain in first episodes of psychosis.

N Khandanpour1, N Hoggard, D J A Connolly.   

Abstract

AIM: To investigate whether imaging is associated with early detection of the organic causes of the first episode of psychosis (FEP).
MATERIALS AND METHODS: Individuals with FEP but no neurological signs referred to a tertiary centre for cerebral magnetic resonance imaging (MRI) or computed tomography (CT) were reviewed retrospectively. Two groups were evaluated with either CT or MRI; the two groups were independent and no individual underwent both CT and MRI.
RESULTS: One hundred and twelve consecutive cerebral MRI and 204 consecutive CT examinations were identified. Three (2.7%) individuals had brain lesions [brain tumour and human immunodeficiency virus (HIV) encephalopathy] potentially accountable for the psychosis at MRI. Seventy patients (62.5%) had incidental brain lesions, such as cerebral atrophy, small vessel ischaemic changes, unruptured Circle of Willis aneurysm, cavernoma, and arachnoid cysts at MRI. Three patients (1.5%) had focal brain lesions (primary or secondary tumours) potentially accountable for the psychosis at CT. One hundred and thirty-three patients (65.2%) had incidental brain lesions unrelated to the psychosis on CT scan. There was no significant difference between MRI and CT imaging in detecting organic disease potentially responsible for FEP (p < 0.001).
CONCLUSION: Routine MRI or CT imaging of the brain is unlikely to reveal disease leading to a significant change in management. MRI was comparable with CT in terms of diagnosis of both pathological and incidental cerebral lesions. Therefore, routine brain structural imaging of FEP in patients without focal neurology may not be routinely required and if imaging is requested then CT may function equally as well as MRI as the first-line investigation.
Copyright © 2012 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22959259     DOI: 10.1016/j.crad.2012.07.010

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  9 in total

1.  Clinical use of neuro-imaging in psychiatric patients at the Charlotte Maxeke Johannesburg Academic Hospital.

Authors:  Bokang L Letlotlo; Lavinia D Lumu; Mahomed Y H Moosa; Fatima Y Jeenah
Journal:  S Afr J Psychiatr       Date:  2021-05-28       Impact factor: 1.550

2.  The clinical value of brain computerised tomography in a general hospital psychiatric service.

Authors:  Usha Chhagan; Jonathan K Burns
Journal:  S Afr J Psychiatr       Date:  2017-06-01       Impact factor: 1.550

3.  To scan or not to scan? Examining the controversial issue of performing neuroimaging in adolescent patients presenting to a tertiary psychiatric inpatient unit.

Authors:  Zureida Khan; Anusha Lachman
Journal:  S Afr J Psychiatr       Date:  2020-02-06       Impact factor: 1.550

4.  Cerebrospinal fluid findings in patients with psychotic symptoms-a retrospective analysis.

Authors:  Tim W Rattay; Pascal Martin; Debora Vittore; Holger Hengel; Idil Cebi; Johannes Tünnerhoff; Maria-Ioanna Stefanou; Jonatan F Hoffmann; Katrin von der Ehe; Johannes Klaus; Julia Vonderschmitt; Matthias L Herrmann; Paula Bombach; Hazar Al Barazi; Lena Zeltner; Janina Richter; Klaus Hesse; Kathrin N Eckstein; Stefan Klingberg; Dirk Wildgruber
Journal:  Sci Rep       Date:  2021-03-30       Impact factor: 4.379

5.  The need for neuroimaging in first manifestations of psychiatric symptoms.

Authors:  Christian Saleh; Ulrich Seidl; Gregor Hutter; Margret Hund-Georgiadis
Journal:  Surg Neurol Int       Date:  2021-09-06

6.  Retrospective study on structural neuroimaging in first-episode psychosis.

Authors:  Ricardo Coentre; Amilcar Silva-Dos-Santos; Miguel Cotrim Talina
Journal:  PeerJ       Date:  2016-05-26       Impact factor: 2.984

7.  Frequency and pattern of radiological and laboratory investigations in patients with mental illnesses: A study from North Rajasthan.

Authors:  Dhanesh K Gupta; Navratan Suthar; Vikram Singh; Mitesh Bihari; Vijay Kumar; Kamal K Verma; Roop Sidana; Somnath Sengupta; Mahender Singh Bhadoriya
Journal:  Indian J Psychiatry       Date:  2016 Apr-Jun       Impact factor: 1.759

8.  Time for a change of practice: the real-world value of testing for neuronal autoantibodies in acute first-episode psychosis.

Authors:  Thomas A Pollak; Belinda R Lennox
Journal:  BJPsych Open       Date:  2018-07-16

Review 9.  Psychotic disorders in late life: a narrative review.

Authors:  Rajesh R Tampi; Juan Young; Rakin Hoq; Kyle Resnick; Deena J Tampi
Journal:  Ther Adv Psychopharmacol       Date:  2019-10-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.